Susha Dinesh

Ms. Susha Dinesh

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

20 January 2025 in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Verified
Journal Article
Open access
PDF file
HRHannah Raji
Hannah Raji
SDSusha Dinesh
Susha Dinesh
SSSAMEER SHARMA
SAMEER SHARMA
This abstract delves into the intricate nature of impulsivity and its ramifications across psychiatric disorders, leveraging advancements in neuroimaging and psychological studies. It elucidates diverse facets of impulsivity, encompassing response, choice, and tendencies, emphasizing its pivotal role in executive functioning and social development. The intricate interplay of hormonal influences, specifically cortisol, adrenaline, and testosterone, is meticulously examined, unveiling associations between elevated cortisol levels, excessive adrenaline release, and heightened impulsivity. The ventromedial prefrontal cortex (VMPFC) assumes a central role in decision-making and emotional regulation, demonstrating correlations with conditions, such as antisocial behavior and mood disorders. Substantial contributions from neurotransmitters like dopamine and serotonin to impulsive behavior underscore the imperative need for genetic and neurochemical investigations to identify factors crucial for effective management. Interconnections between stress, impulsivity, and decision-making are accentuated, particularly in mood disorders. Hormones, such as leptin and ghrelin, in conjunction with the hypothalamic–pituitary–adrenal axis, play pivotal roles in conditions like major depressive disorder. Concurrently, leptin resistance exerts influence over appetite and mood regulation. The nexus between impulsivity and substance use disorders emphasizes the intricate involvement of neurobiological, neurotransmitter, and genetic components, guiding targeted interventions. Recognition of gender-specific impulsive behaviors and hormonal influences is imperative for tailoring treatment plans. Advocating a comprehensive approach that integrates hormonal assessments with clinical evaluations, taking into account the neurobiological context, is essential. While serotonin systems show promise for treating impulsive aggressiveness, challenges encompass intricate hormonal interactions, ethical considerations, limited treatment options, and the necessity for individualized approaches. Addressing these intricacies is pivotal for advancing knowledge and formulating effective interventions for Impulsive Control Disorders.

1 April 2024 in Central Nervous System Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SGSaumya Gupta
Saumya Gupta
SDSusha Dinesh
Susha Dinesh
SSSAMEER SHARMA
SAMEER SHARMA
Background:: The gut-brain axis (GBA) is a bidirectional signaling channel that facilitates communication between the gastrointestinal tract and the brain. Recent research on the gut-brain axis demonstrates that this connection enables the brain to influence gut function, which in turn influences the brain and its cognitive functioning. It is well established that malfunctioning of this axis adversely affects both systems' ability to operate effectively. Objective:: Dysfunctions in the GBA have been associated with disorders of gut motility and permeability, intestinal inflammation, indigestion, constipation, diarrhea, IBS, and IBD, as well as neuropsychiatric and neurodegenerative disorders like depression, anxiety, schizophrenia, autism, Alzheimer's, and Parkinson's disease. Multiple research initiatives have shown that the gut microbiota, in particular, plays a crucial role in the GBA by participating in the regulation of a number of key neurochemicals that are known to have significant effects on the mental and physical well-being of an individual. Methods:: Several studies have investigated the relationship between neuropsychiatric disorders and imbalances or disturbances in the metabolism of neurochemicals, often leading to concomitant gastrointestinal issues and modifications in gut flora composition. The interaction between neurological diseases and gut microbiota has been a focal point within this research. The novel therapeutic interventions in neuropsychiatric conditions involving interventions such as probiotics, prebiotics, and dietary modifications are outlined in this review. Results:: The findings of multiple studies carried out on mice show that modulating and monitoring gut microbiota can help treat symptoms of such diseases, which raises the possibility of the use of probiotics, prebiotics, and even dietary changes as part of a new treatment strategy for neuropsychiatric disorders and their symptoms. Conclusion:: The bidirectional communication between the gut and the brain through the gut-brain axis has revealed profound implications for both gastrointestinal and neurological health. Malfunctions in this axis have been connected to a range of disorders affecting gut function as well as cognitive and neuropsychiatric well-being. The emerging understanding of the role of gut microbiota in regulating key neurochemicals opens up possibilities for novel treatment approaches for conditions like depression, anxiety, and neurodegenerative diseases.

20 January 2024 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
DBDiya Bhalla
Diya Bhalla
SDSusha Dinesh
Susha Dinesh
SSSAMEER SHARMA
SAMEER SHARMA
GSGonchigar Jayanna Sathisha
Gonchigar Jayanna Sathisha

24 August 2023 in The Protein Journal
Verified
Journal Article
Closed access
PDF file
SRS. V. Ramprasadh
S. V. Ramprasadh
SRSanthosh Rajakumar
Santhosh Rajakumar
SSS. Srinivasan
S. Srinivasan
SDSusha Dinesh
Susha Dinesh
SSSAMEER SHARMA
SAMEER SHARMA
RCRajan Chourasiya
Rajan Chourasiya

1 February 2024 in Current Diabetes Reviews
Verified
Journal Article
Closed access
PDF file
SDSusha Dinesh
Susha Dinesh
SSSAMEER SHARMA
SAMEER SHARMA
RCRajan Chourasiya
Rajan Chourasiya
Diabetes mellitus is a condition caused by a deficiency in insulin production or sensitivity that is defined by persistent hyperglycemia as well as disturbances in glucose, lipid, and protein metabolism. Uncurbed diabetes or incessant hyperglycemic condition can lead to severe complications, including renal damage, visual impairment, cardiovascular disease, neuropathy, etc., which promotes diabetes-associated morbidity and mortality rates. The therapeutic management of diabetes includes conventional medications and nutraceuticals as complementary therapies. Nutraceuticals are bioactive compounds derived from food sources that have health-promoting properties and are instrumental in the management and treatment of various maladies. Nutraceuticals are clinically exploited to tackle DM pathogenesis, and the clinical evidence suggests that nutraceuticals can modulate biochemical parameters related to diabetes pathogenesis and comorbidities. Hypoglycemic medicines are designed to mitigate DM in traditional medicinal practice. This review intends to emphasize and comment on the various therapeutic strategies available to manage this chronic condition, conventional drugs, and the potential role of nutraceuticals in managing the complexity of the disease and reducing the risk of complications. In contrast to conventional antihyperglycemic drugs, nutraceutical supplements offer a higher efficacy and lesser adverse effects. To substantiate the efficacy and safety of various functional foods in conjunction with conventional hypoglycemic medicines, additional data from clinical studies are required.